Catamaran Corp (CTRX)

61.45
0.02 0.03
Prev Close 61.43
Open 61.44
Day Low/High 61.42 / 61.47
52 Wk Low/High 39.40 / 61.48
Volume 826.88K
Avg Volume 2.71M
Exchange
Shares Outstanding 208.01M
Market Cap 12.79B
EPS 1.53
Div & Yield N.A. (N.A)

Latest News

Verizon Nixing Discounted Phones May Turn Into a Self-Inflicted Wound

Verizon Nixing Discounted Phones May Turn Into a Self-Inflicted Wound

Jim Cramer delves into Verizon ending its discounted phones and the impact to the carrier. He also touches on Warren Buffett's Precision Castparts buyout and what it means for Alcoa.

Jim Cramer Says Rethink Alcoa After Buffett Buys Precision Castparts

Jim Cramer Says Rethink Alcoa After Buffett Buys Precision Castparts

Jim Cramer answers viewers’ Twitter questions Monday from the floor of the New York Stock Exchange.

OptumRx, Catamaran Complete Combination

OptumRx, Catamaran Complete Combination

Optum announced the completion of its combination with Catamaran Corporation (NASDAQ: CTRX) (TSX: CCT).

Catamaran (CTRX) Is Today's Strong And Under The Radar Stock

Catamaran (CTRX) Is Today's Strong And Under The Radar Stock

Trade-Ideas LLC identified Catamaran (CTRX) as a strong and under the radar candidate

Computer Software & Services Stocks On The Rise With Help From 3 Stocks

Computer Software & Services Stocks On The Rise With Help From 3 Stocks

TheStreet highlights 3 stocks pushing the computer software & services industry higher today.

New Lifetime High Reached: Catamaran (CTRX)

New Lifetime High Reached: Catamaran (CTRX)

Trade-Ideas LLC identified Catamaran (CTRX) as a new lifetime high candidate

Don't Miss Today's Strong And Under The Radar Stock: Catamaran (CTRX)

Don't Miss Today's Strong And Under The Radar Stock: Catamaran (CTRX)

Trade-Ideas LLC identified Catamaran (CTRX) as a strong and under the radar candidate

Express Scripts Keeps Getting Better

Will it get involved in health care sector's deal mania?

CVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7B

CVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7B

The deal will help CVS expand its ability to provide prescriptions to assisted-living and long-term-care facilities, serving the rapidly aging American senior patient population.

First-Quarter Deals Near $1 Trillion Mark Highest Value Since 2007

First-Quarter Deals Near $1 Trillion Mark Highest Value Since 2007

Mega deals from strategic players across a variety of industries pushed first-quarter deals to the highest value since 2007.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Catamaran Corporation And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Catamaran Corporation And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

CATAMARAN SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Catamaran Corp. Over The Proposed Sale Of The Company To UnitedHealth Group, Inc. - CTRX

CATAMARAN SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Catamaran Corp. Over The Proposed Sale Of The Company To UnitedHealth Group, Inc. - CTRX

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Catamaran Corp.

Catamaran (CTRX) Stock Falls Today Following UnitedHealth Group Acquisition Announcement

Catamaran (CTRX) Stock Falls Today Following UnitedHealth Group Acquisition Announcement

Shares of Catamaran (CTRX) declined in afternoon trading Tuesday, one day after UnitedHealth Group announced its agreement to buy the Illinois pharmacy benefits management firm for $12.8 billion.

Big Pharma Merger Monday Deals Disregard Biotech Bubble Talks

Big Pharma Merger Monday Deals Disregard Biotech Bubble Talks

Large pharmas continued the shopping spree, paying no attention to whispers of a biotech bubble.

Jim Cramer's 'Mad Money' Recap: Good Headlines Make All the Difference

Jim Cramer's 'Mad Money' Recap: Good Headlines Make All the Difference

It's nice to see the flow of money has reversed from last week's relentless selloff, Cramer says.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Catamaran Corporation And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Catamaran Corporation And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

Market News: Auspex Pharmaceuticals, Catamaran, Horizon Pharma

Market News: Auspex Pharmaceuticals, Catamaran, Horizon Pharma

The stock markets in the United States rallied today driven by optimism among investors that central banks will support the global economic growth. The markets also benefitted from reports on corporat...